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Fenestration morphology is a remarkable example of the synergy 
between structure and function. Through a better understanding of 
fenestration structure our understanding of its function will be 
enhanced.  
Fenestrations are transcellular pores that act as fundamental 
biological ultra-filters allowing diffusive and convective passage of 
substrates across cells without relying on endocytosis or other 
receptor-mediated mechanisms. They facilitate passive transfer of 
substances such as lipoproteins [1], parasites [2], pharmacological 
agents [3] and gene transfer vectors [4]. Fenestrated cells are highly 
conserved in evolution and have been documented in all species from 
fish to humans [5-9] and even in the phloem vascular system of 
higher plants [10]. In animals they are found in several cell types 
including liver sinusoidal endothelial cells (LSECs) [11] (Figure 1), 
glomerular endothelial cells [5], endothelial cells of the area postrema 
[12] and the posterior pituitary [13] of the brain, as well as numerous 
cancers [14]. All of these tissues require unimpeded transfer of 
substances between blood and surrounding cells. Fenestrations are 
essential for human health and loss of fenestrations in LSECs results 
in impaired lipid, drug and insulin transfer [15-17] and regeneration 
[18]. However, despite their ubiquity and biological importance, we 
are only beginning to understand the molecular and cellular pathways, 
and the spatial and temporal sequence of events involved in 
fenestration formation. Here, we propose a novel sieve-raft hypothesis 
[19] as a key mechanism regulating fenestrations in the LSEC. 
 
Liver Sinusoidal Endothelial Cells (LSECs) 
 
LSECs line the liver sinusoids which form the reticulated network 
of blood vessels of the highly vascular liver. The fractal dimension of 
the sinusoidal vessels (a measure of complexity) exceeds two 
indicating the space-filling characteristic of the sinusoids [20]. This 
degree of vascularity facilitates the exchange of substrates between 
blood and the liver and provides an extensive endothelial surface area 
for interactions with circulating immune cells and various colloid and 
soluble macromolecular waste products. The morphology of  LSECs 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
further facilitates cellular interactions and transfer of material from 
the blood through the presence of fenestrations which are between 50 
and 200 nm in diameter and too small to be observed with 
conventional light microscopy. They are mostly found in attenuated 
areas of the cell cytoplasm, typically less than 100 nm in thickness. 
Fenestrations are bound by the plasma membrane and are discrete 
regions of fusion of the apical and basolateral membranes of the cell. 
They are complete gaps in the endothelial lining, lacking either a 
diaphragm or underlying basal lamina. In the LSEC, fenestrations are 
either scattered individually across the endothelial surface or are 
arranged in groups of between 10 and 100 fenestrations, termed ‘liver 
sieve plates’, reflecting their role as a filter or sieve [21] (Figure 1A). 
There are approximately 3-20 fenestrations per m2 of endothelial 
surface and between 2-20% of the surface of the LSEC are covered by 
fenestrations [6, 22-27]. Between 60-75% of fenestrations are found 
within sieve plates in rats [22]. Sieve plates are particularly apparent in 
healthy young liver endothelial cells and are decreased with actin 
disruptors such as cytochalasin B [13]. In isolated LSECs, there are 
usually tens of sieve plates present in the cytoplasmic extension of a 
single cell, representing many hundreds or even thousands of 
fenestrations per cell [28, 29]. Fenestrations have been detected using 
a variety of methodologies (transmission electron microscopy, 
scanning electron microscopy, electron tomography, freeze fracture 
microscopy, cryo-electron microscopy, atomic force microscopy, and 
structured illumination microscopy [23, 24, 30-32]) (Figure 1). Even 
so, the exact size and morphology of fenestrations are difficult to 
measure [30].  
 
Biological function of fenestrations 
 
The fenestrated LSEC acts as a filter and hence was termed ‘the 
liver sieve’ [33-35]. In the liver fenestrations permit the passage of a 
wide range of substrates (plasma and substrates within plasma, plasma 
proteins including albumin, smaller lipoproteins, colloidal particles 
and polystyrene microspheres) into the underlying space of Disse 
although the proportion of each substrate that enters the space of 
Disse via fenestrations remains unknown [36]. The diaphragmed 
fenestrations of the kidney facilitate the movement of water and other 
dissolved substances movement from the blood into the Bowmans 
capsule to produce urine [37]. 
Both diameter and frequency of fenestrations determines diffusive 
and convective transfer across the LSEC [38]. It is possible to 
quantify the effects of changes in the liver endothelium and 
fenestrations on the transfer of substrates such as lipoproteins by 
application of the engineering principles related to membrane 
filtration, specifically ultrafiltration. The reduction in the diameter of 
fenestrations will also influence the size of particles that are able to 
transfer across the endothelium. A summary of the physiological roles 
the fenestrations of the LSEC are listed in Table 1. 
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There are numerous reports of diseases and pathological processes 
that influence fenestrations, including: liver disease [42, 48, 49], liver 
toxins [50-53], [54, 55], systemic disease [56, 57], and other liver 
processes such as aging [36, 58-60], These changes have not usually 
been diagnostic [61, 62] but the overall trends are that: (1) acute 
toxic injury and acute medical conditions are associated with loss of 
endothelial integrity characterized by gap formation and (2) sub-acute 
and chronic conditions have been associated with defenestration and 
reduced porosity.  
Age-related pseudocapillarization is now well documented [58, 
63, 64]. This loss of endothelial fenestrations, endothelial thickening 
and increased deposition of extracellular matrix with age has been 
shown to impact upon liver function, in particular leading to a 
reduction in the transfer of lipids and pharmaceutical agents [1, 3, 
65]. Through this mechanism age-related pseudocapillarization is 
thought to contribute to the development of age-related diseases. 
 
Fenestration regulation and dynamics 
 
Fenestrations are dynamic structures that change in frequency and 
diameter in response to numerous stimuli in vitro. In vivo it is likely 
that fenestrations open and close in response to various stimuli such 
as inflammation, dietary fat load and/or circulating vasoactive 
cytokines and hormones (Table 2) [66, 67]. Local paracrine and 
autocrine factors presumably establish and maintain porosity at a level 
required for health. There are several issues that confound the 
interpretation of studies of regulatory factors. LSECs isolated from 
rat livers have been the major model for studying fenestration biology. 
This is dependent on the methodology with some methods failing to 
generate well fenestrated cells [29, 68, 69]. Isolated LSECs are only 
viable for 1-2 days and there is a dramatic change in fenestrations 
during this period [68, 70-73]. Maintenance of fenestrations in 
isolated LSECs requires VEGF [28, 68, 70] and extracellular matrix 
derived from the liver [73, 74]. It is likely that fenestrations are 
regulated in vivo by a variety of paracrine and circulating factors as 
well as the extracellular matrix and of course these are absent in 
isolated cell studies [69, 70].  
 
Conventional wisdom on fenestrations 
 
It is widely accepted that the actin cytoskeleton has a role in 
maintaining fenestrations. Sieve plates are supported by the actin 
cytoskeleton with structures such as the fenestrae-associated 
cytoskeleton ring, sieve plate associated cytoskeleton, fenestrae 
forming center, and defenestration-associated center [30, 32, 75-81]. 
Agents that disrupt actin such as cytochalasin D and latrunculin A 
increase the number of fenestrations, usually in the order of two-fold, 
associated with a marked reduction in sieve plates [13, 95, 104, 135]. 
The key role of calcium in regulating fenestrations through effects 
on the cytoskeleton was reported by Gatmaitan et al [71]. Several 
agents were identified that reduced the diameter of fenestrations by 
about 20% in rat LSECs. All were associated with an increase of 
intracellular calcium by two-three folds. Agents that reduced 
fenestration diameter included serotonin, metoclopramide, 
propranolol, indomethacin and calcium ionophore while agents with 
no activity included verapamil, diltiazem, nifedipine, ketanserin, 
imipramine, mianserin, pertussis toxin and dexamethasone. Calcium 
channel blockers (diltiazem, verapamil and nifedipine) and the 
calcium chelator, EGTA reversed the effect of serotonin. In addition, 
the increase of calcium induced by serotonin was linked with 
phosphorylation of myosin light chain and reduced levels of cAMP 
Figure 1. Microscopy of LSEC fenestrations and the LSEC membrane. Figure 1A is a scanning electron micrograph of an isolated LSEC in culture. The 
micrograph clearly displays fenestrations, examples are denoted by an asterix (*), arranged in groups (sieve plates) or individually. The fenestrations are 
located in the thin cytoplasmic extensions of the cell, distal to the nucleus (N) Scale bar = 5 µm. Figure 1B is a transmission electron micrograph of perfusion 
fixed liver, the unique architecture of the sinusoid can be seen. The very thin endothelium (E) is perforated with fenestrations (#), allowing passage of 
substrates into the hepatocytes (H) for metabolism, storage and detoxification Scale bar = 2 µm. Figure 1C is a micrograph prepared by 3D structured 
illumination microscopy. The LSECs have been stained with Bodipy FL C5 ganglioside GM1, a marker for rafts (green) and Cell-Mask Orange, a cell membrane 
marker (orange). There is an inverse distribution between liver sieve plates and membrane rafts. Some sieve plates are identified by an arrow (→) and 
fenestrations can be resolved within the sieve plates. Scale bar = 1 µm. 
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[71]. In another study, serotonin reduced the diameter of 
fenestrations by 20% associated with an increased thickness of the 
fenestrae-associated actin ring by 6 nm, confirming the interaction 
between serotonin, actin and fenestrations [82]. More recently the 
selective serotonin receptor agonist, 22,5-dimethoxy-4-
iodoamphetamine (DOI) has been shown to be a potent modulator of 
fenestrations through VEGF mediated mechanisms [18, 83]. 
In endothelial cells, VEGF activates cell division, angiogenesis and 
vascular permeability. VEGF increases intracellular calcium, 
phosphorylates myosin light chain and causes retraction of the 
cytoskeleton [84, 85]. VEGF generates fenestrations and caveolae in a 
number of different endothelial cells included tumor [86], renal [87] 
and adrenal [88] endothelial cells. In the liver, hepatocytes produce 
VEGF which acts of liver endothelial cells via the receptors: VEGFR-
1 (Flt-1) and VEGFR-2 (KDR/Flk-1) of which VEGFR-2 is the 
most important [28, 89, 90]. VEGF is expressed more highly in the 
pericentral regions reflecting hypoxia which is the primary stimulus 
for VEGF production, whereas VEGFR-2 is found along the entire 
sinusoidal endothelium [91].  
In isolated liver endothelial cells, VEGF increases porosity about 
twofold, mostly through its effects on the number of fenestrations 
[28, 92]. VEGF converts punctuate caveolin-1 staining to aggregates 
of staining, the majority of which are located at the periphery of the 
LSECs. VEGF did not change total caveolin-1 protein expression. 
Indeed caveolin-1 labeling might eventually appear reduced by the 
redistribution of caveolin-1 onto the markedly increased number of 
fenestrations [93].  
Systemic VEGF exposure generated by VEGF-expressing CHO 
cells implanted into nude mice stimulated mitosis and proliferation of 
liver endothelial cells and led to increased complexity and branching 
of sinusoids [89]. Conversely, transgenic inhibition of VEGF 
receptors altered the hepatic endothelium of early postnatal mice, 
including loss of endothelial lining in many sinusoids [94] and was 
associated with defenestration and hyperlipidemia [95], this integral 
role of VEGF in fenestration development has also been confirmed in 
the kidney [96]. VEGF is considered to be the major cytokine 
involved in the regulation of fenestrations [87]. 
Members of the Rho-like GTPase family also regulate the actin 
cytoskeleton in endothelial cells and are critical for membrane fusion 
[97]. Inhibition of the Rho pathway by C3-transferase caused 
reduction of myosin light chain phosphorylation, loss and retraction 
of actin filaments and led to increased porosity and the formation of 
large gaps. Activating Rho with lysophosphatidic acid increased 
myosin light chain phosphorylation and actin filaments and led to 
defenestration [98].  
Other factors that influence fenestrations, presumably via actions 
on actin are endothelin 1 and nitric oxide. Endothelin 1 increased 
intracellular calcium and decreased fenestration diameter whereas 
prostaglandin decreased intracellular calcium and increased 
fenestration diameter [99]. In another study endothelin 1 decreased 
diameter of fenestrations from 123 nm to 46 nm, an effect abolished 
by blockade of the ETB-R, and only partially abolished by ETA-R 
antagonism [100]. Antagonism of the ETA-R caused a marked 
increase in fenestration diameter associated with gap formation [101]. 
Nitric oxide is involved in the maintenance of fenestrations. Caveolin-
1 and endothelial nitric oxide co-locate in the cell membranes lining 
fenestrations and caveolin-1 is attached to actin [102]. Activation of 
calmodulin by increased levels of intracellular calcium releases 
endothelial nitric oxide synthase from caveolin-1, thereby increasing 
production of nitric oxide [93]. Importantly, it has been shown that 
the effects of VEGF on the phenotype of LSECs require autocrine 
production of nitric oxide [69]. 
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On the basis of some studies showing the expression of caveolin-1 
in fenestrations and the similarity in their dimensions and 
appearances, it had been proposed that fenestrations are a form of 
caveolae and that caveolin-1 is a possible marker [45, 93]. While the 
role of caveolin 1 in the formation of diaphragmed fenestrations of 
the kidney glomerular endothelium had already been ruled out [37], 
we investigated its role in the non-diaphragmed fenestrations in the 
liver using caveolin-1 knockout mice and performed electron 
microscopic immunogold caveolin-1 staining in wild type mice. 
Fenestrations were normal in the knockout mice and caveolin-1 did 
not decorate fenestrations in wild type mice. Therefore 
undiaphragmed and diaphragmed fenestrations are unlikely to be 
caveolae and do not require caveolin-1 for their formation [103]. In 
addition, PV-1 had been identified as marker of fenestrations, but has 
recently been shown to be required for diaphragm formation on 
diaphragmed fenestrations, but is not present in the LSEC at all 
[104]. 
Fenestrations form as a result of fusion of opposing plasma 
membranes [79, 105-107] by a process of membrane or pore fusion 
[108]. In other cell types, this process generates membrane pores with 
diameters of 100-500 nm [109] and is highly sensitive to actin-
modifying agents [97]. The actin cytoskeleton prevents the 
development of protein-free patches in membranes and subsequent 
contact of protein-free membranes domains that are required for 
membrane fusion to be initiated (‘actin barrier’). Actin is then 
involved in the subsequent development and stabilization of fusion 
pores [97, 108]. Thus there is a biphasic dose-dependent response to 
actin modifying agents with low doses stimulating fusion and high 
doses inhibiting fusion [97]. It has been proposed that actin 
depolymerization is initially required to allow membranes to dock, 
whereas the final membrane fusion process requires the re-
establishment of an actin network [97]. The time for the opening of a 
fusion pore in other cells is less than 20 minutes [109] which 
provides some estimate of the rate of fenestration formation. In 
LSECs, actin reorganization might allow more cell membrane fusion 
to be initiated by removing the intervening actin barrier, leading to 
increased fenestrations. This is consistent with the observation that 
actin disruptors cause increased fenestrations and decreased sieve 
plates. On the other hand, a different level of actin reorganization will 
impede the subsequent completion of membrane fusion, causing 
defenestration. The effects may also be time-dependent and many 
studies showing increased fenestration were measured over longer 
periods than those showing reduced fenestrations. The role of various 
fusion proteins (eg SNAREs, Rabs, dynamin) [108, 110] and other 
pathways involved in the regulation of membrane fusion [97, 108] 
have not been investigated with respect to fenestration formation. 
However, a complete peristomal ring of sterols, considered to 
contribute to membrane fusion, has been detected lining the rim of 
fenestrations, but not around gaps [107]. This was one of the first 
indications that the cell membrane, its composition and the 
arrangement of these components may be key in fenestration 
formation and maintenance. 
 
The Sieve-Raft Hypothesis 
 
The cell membrane and its distinct and specialized regions known 
as microdomains determine myriad biological processes including cell 
signalling, protein trafficking, cell viability, and cell movement. 
Recently we have shown that membrane microdomains, also known as 
lipid raft and non- raft regions, also regulate fenestrations [19]. This 
work has been described as a “a major advance in our understanding” 
of the mechanisms that regulate the formation of sieve plates and 
fenestrations” [111]. Lipid rafts are a distinct type of membrane 
microdomains that are enriched in sphingolipid, cholesterol and 
protein. They vary in size from 10-200 nm, and may aggregate to 
form micrometre-sized structures [112]. Sphingolipids and 
cholesterol engender membrane stability and provide a platform for 
many membrane proteins such as membrane receptors. Rafts are 
tethered to the actin cytoskeleton through protein complexes such an 
ezrin-radixin-moesin and stabilin which have a pivotal role in 
maintaining their structure and integrity [113, 114]. The size of 
individual membrane rafts, like that of fenestrations, is below the 
limits of resolution of light microscopy and their visualization with 
fluorescence microscopy has had limited success. While the presence 
and localisation of rafts has suffered from important controversies due 
to isolation methodologies and the inability to reliably visualize them, 
major technological advances in microscopy such as Structured 
Illuminated Microscopy (SIM), lipidomic and proteomic platforms 
such as mass spectrometry and development of model systems are 
leading advances in the field [112]. It is now widely accepted that 
assemblies of sphingolipids, cholesterol and proteins into raft 
platforms, or liquid- ordered phases of the membrane, and their 
Figure 2. The Sieve-Raft hypothesis: the composition and arrangement of lipids in the cell membrane is paramount in determining fenestration formation and 
cell function. We propose that fenestrations form in non-raft microdomains of the lipid bilayer and that rafts and actin engender membrane stability, while 
limiting fenestration formation.  
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corresponding liquid disordered phase non- raft neighbours and the 
patterns of phase segregation that occur, are vital for signalling, 
membrane vesiculation, trafficking and viral infection. 
In 2010, in collaboration with our colleagues at UC Davis, we 
utilised SIM to resolve the topography of fenestrations and sieve 
plates and for the first time show a detailed three-dimensional map of 
their structure [32]. When we stained the plasma membrane of the 
LSEC, we noted discrete membrane structures that were intercalated 
between the sieve plates. On the basis of their size and appearance we 
postulated that these structures are membrane rafts and potentially 
involved in the regulation of sieve plates. In order to test this 
hypothesis, we then applied 3D-SIM, Total Internal Refractive 
Fluorescence Microscopy (TIRFM) and Scanning Electron 
Microscopy (SEM) techniques to isolated LSECs and visualized 
membrane rafts, fenestrations and actin under various conditions [19]. 
These studies indicated that there is a clear inverse distribution 
between fenestrations and membrane rafts and that fenestrations form 
in non- raft regions of LSECs once the membrane-stabilizing effects 
of actin cytoskeleton and membrane rafts are diminished (Figure 1). 
We termed this the ‘sieve-raft hypothesis’ (Figure 2). 
The final step in the formation of fenestrations requires the 
juxtaposition of the apical and basolateral membranes in very thin 
areas of cell cytoplasm. This process of cell membrane bending and 
fusion requires ATP and large-scale deformations of the lipid bilayers 
[13]. Recently it has been shown that plasma membrane fusion can 
only occur when lipid rafts are depleted [113]. Further it has been 
shown that membrane fusion and pore formation is restricted by a 
dynamic resistance of the actin network in experimental membrane 
fusion models [74], suggesting that the formation of fenestrations 
requires retraction and or rearrangement of the normal sub-membrane 
actin cytoskeleton. We propose that the final process leading to the 
formation of fenestrations may be similar to the generation of 
membrane vesicles, which also requires disruption of the actin 
cytoskeleton and are associated with increased lipid-disordered, non- 
raft microdomains [115]. Vesiculation occurred spontaneously in 
membranes when line tension associated with rafts was reduced and 
the tethering by actin cytoskeleton released. This is consistent with 
our observation that small pores are seen adjacent to fenestrations in 
the non- raft microdomains of the LSEC. Very recently, the splitting 
apart (fission) of membranes, an essential step prior to apical and 
basolateral membrane fusion, has been shown to be dependent on 
dynamin, GTP release and Phosphatidylinositol 4,5-bisphosphate 
(PIP2) localisation. PIP2 is a phospholipid most enriched in non-raft 
microdomains of the cell membrane [110]. 
The raft-sieve hypothesis is the synthesis of our recent findings 
and current knowledge on membrane biology and outlines that 
transcellular fenestrations form in phase segregated, non- raft domains 
of the plasma membrane (Figure 2). These domains can be uniquely 
identified by their lipid and protein species which impart unique 
biophysical properties to the membrane, providing the 
microenvironment in which fenestrations can form. Cell plasma 
membrane curvature, deformation, vesiculation and elasticity are core 
fields for cell membrane research. Regulation of these properties are 
essential steps in many fundamental cell processes such as endocytosis 
[116], intercellular nanotube formation [117], red blood cell 
deformation for blood flow through capillaries [118], ovum 
fertilisation by sperm in meiotic reproduction [119] as well as the 
focus of our own research on fenestrations in the LSEC. Underlying 
these processes is the structural contribution of the lipid and protein 
content on the plasma membrane.  
High cholesterol and sphingolipid components have been shown 
to engender membrane stability and reduced elasticity, and reduction 
in the concentration of these molecules leads to an increased capacity 
for membrane curvature [118]. The lipid content of bacterial 
membranes has been specifically shown to alter in order to induce 
membrane curvature in helices formation [120]. Definition of these 
fundamental biological interactions in other cells has led to powerful 
insight into viral and bacterial infection of cells and reproduction, yet 
the lipid and protein properties of the biologically essential 
fenestrated cell membrane are unknown.  
We believe that the Sieve-Raft hypothesis may underlie 
fenestration formation in all fenestrated cells and suggest that while 
more experimental data is needed, the next step forward in greater 
understanding of the structural biology of fenestrations is probing cell 
membranes. Identification and localisation of the component lipids 
and proteins, and interrogation of the interactions of these 
constituents and how they form fenestrations requires technologies 
and tools not previously applied to study fenestrations. An innovative 
correlative approach using cutting edge lipidomics, proteomics and 
visualisation will provide detailed information regarding cell 
membrane biology and how specific patterns of interaction between 
lipids and proteins can result in the unique biological phenomena that 
is cellular fenestrations. 
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